Alzheimer’s, cancer and rare disease research to benefit from landmark MRC-AstraZeneca compound collaboration

The Medical Research Council will today (31 Oct) announce £7 million of funding for 15 research projects awarded through its groundbreaking collaboration with innovative pharmaceutical company AstraZeneca.